Breast cancer in low-middle income countries: abnormality in splicing and lack of targeted treatment options FZ Francies, R Hull, R Khanyile, Z Dlamini American journal of cancer research 10 (5), 1568, 2020 | 177 | 2020 |
MicroRNA and alternative mRNA splicing events in cancer drug response/resistance: potent therapeutic targets R Marima, FZ Francies, R Hull, T Molefi, M Oyomno, R Khanyile, ... Biomedicines 9 (12), 1818, 2021 | 23 | 2021 |
AI and precision oncology in clinical cancer genomics: From prevention to targeted cancer therapies-an outcomes based patient care Z Dlamini, A Skepu, N Kim, M Mkhabele, R Khanyile, T Molefi, S Mbatha, ... Informatics in Medicine Unlocked 31, 100965, 2022 | 21 | 2022 |
AI tools offering cancer clinical applications for risk predictor, early detection, diagnosis, and accurate prognosis: perspectives in personalised care R Khanyile, R Marima, M Mbeje, S Mutambirwa, D Montwedi, Z Dlamini Artificial Intelligence and Precision Oncology: Bridging Cancer Research and …, 2023 | 4 | 2023 |
Society 5.0: Realizing Next-Generation Healthcare Z Dlamini, TV Miya, R Hull, T Molefi, R Khanyile, JF de Vasconcellos Society 5.0 and Next Generation Healthcare: Patient-Focused and Technology …, 2023 | 2 | 2023 |
Genomic Interplay between Neoneurogenesis and Neoangiogenesis in Carcinogenesis: Therapeutic Interventions Z Dlamini, R Khanyile, T Molefi, BP Damane, DO Bates, R Hull Cancers 15 (6), 1805, 2023 | 2 | 2023 |
From incidence to intervention: a comprehensive look at breast cancer in South Africa Z Dlamini, T Molefi, R Khanyile, M Mkhabele, B Damane, A Kokoua, ... Oncology and Therapy 12 (1), 1-11, 2024 | 1 | 2024 |
Alternative splicing events and their clinical significance in colorectal cancer: targeted therapeutic opportunities MA Manabile, R Hull, R Khanyile, T Molefi, BP Damane, NP Mongan, ... Cancers 15 (15), 3999, 2023 | 1 | 2023 |
Overcoming the challenges of phytochemicals in triple negative breast cancer therapy: the path forward M Alaouna, C Penny, R Hull, T Molefi, N Chauke-Malinga, R Khanyile, ... Plants 12 (12), 2350, 2023 | 1 | 2023 |
The SARS-COV-2 Seroprevalence among Oncology Patients M Kgatle, R Das, I Lawal, T Boshomane, K Mokoala, C Gaspar, L Mbokazi, ... Journal of Clinical Medicine 12 (2), 529, 2023 | 1 | 2023 |
Resistance to Chemotherapy in Breast Cancer R Khanyile, TV Miya, N Sekoba, E Rakha, Z Dlamini Overcoming Breast Cancer Therapy Resistance: From Mechanisms to Precision …, 2024 | | 2024 |
Resistance to Endocrine Therapy in Breast Cancer D Demetriou, R Khanyile, Z Mbita, Z Dlamini Overcoming Breast Cancer Therapy Resistance: From Mechanisms to Precision …, 2024 | | 2024 |
Advancing Beyond Breast Cancer Resistance: A Glimmer of Hope Z Dlamini, R Hull, R Khanyile, T Molefi, Z Mbita, A Kokoua Overcoming Breast Cancer Therapy Resistance: From Mechanisms to Precision …, 2024 | | 2024 |
Conclusion: Overcoming chemoresistance in cervical cancer Z Dlamini, R Khanyile, T Molefi, BP Damane, R Hull, R Mehrotra Strategies for Overcoming Chemotherapy Resistance in Cervical Cancer, 179-183, 2024 | | 2024 |
Society 5.0 Healthcare: Ethics, Legal Rights, Human Rights, Safety and Security KRM Blenman, R Hull, C Maimela, T Molefi, R Khanyile, Z Dlamini Society 5.0 and Next Generation Healthcare: Patient-Focused and Technology …, 2023 | | 2023 |
Way Forward for Society 5.0 and Next-Generation Healthcare Z Dlamini, R Hull, R Mehrotra, R Khanyile, T Molefi Society 5.0 and Next Generation Healthcare: Patient-Focused and Technology …, 2023 | | 2023 |
Health Informatics Applications in Healthcare and Society 5.0 R Marima, N Mtshali, P Phillips, T Molefi, R Khanyile, Z Mbita, M Mbeje, ... Society 5.0 and Next Generation Healthcare: Patient-Focused and Technology …, 2023 | | 2023 |
THG-009 ([123I]-PARPi) SPECT imaging in the management of oncology patients M Sathekge, Y Mzizi, J Van Zyl, F Van Deventer, K Mokoala, S Bassa, ... Journal of Nuclear Medicine 64 (supplement 1), P1207-P1207, 2023 | | 2023 |